WM
DXCM icon

WS Management’s DexCom DXCM Stock Holding History

WS Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-240,300
Closed -$16.2M – 49
2025
Q3 		$16.2M Buy
+240,300
New +$19M 1.76% 20
2025
Q2 		– Sell
-50,000
Closed -$3.41M – 44
2025
Q1 		$3.41M Buy
+50,000
New +$4.08M 0.38% 36
2024
Q3 		– Sell
-200,000
Closed -$22.7M – 56
2024
Q2 		$22.7M Hold
200,000
– – 1.67% 16
2024
Q1 		$27.7M Sell
200,000
-106,000
-35% -$13.3M 1.75% 17
2023
Q4 		$38M Sell
306,000
-275,100
-47% -$28.1M 2.25% 10
2023
Q3 		$54.2M Buy
581,100
+18,000
+3% +$2.03M 4.37% 6
2023
Q2 		$72.4M Buy
563,100
+137,500
+32% +$16.6M 6.05% 3
2023
Q1 		$49.4M Buy
+425,600
New +$47.6M 5.23% 5
2019
Q3 		– Sell
-214,000
Closed -$8.02M – 66
2019
Q2 		$8.02M Buy
214,000
+14,000
+7% +$440K 0.52% 39
2019
Q1 		$5.96M Buy
+200,000
New +$7.03M 0.36% 44

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

WS Management's DXCM Position: Q2 2025 in Review

WS Management sold out of DexCom (DXCM) in Q2 2025, closing a stake of 1,949 shares — an estimated $133K sold.

WS Management first reported a position in DXCM in Q1 2023 and held it in 3 quarters. The position peaked at $24.4M in Q3 2023. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • WS Management reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • WS Management sold 1,949 DexCom shares in Q2 2025, an estimated $133K.
  • WS Management first reported a position in DexCom in Q1 2023 and held it in 3 quarters.
  • WS Management's DexCom position peaked at $24.4M in Q3 2023.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on WS Management's 13F filing for Q2 2025, filed 14 Aug 2025.